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Abstract
Coronavirus M protein is an essential component of virion and plays pivotal roles in virion assembly, budding and
maturation. The M protein is integrated into the viral envelope with three transmembrane domains flanked by a short
amino-terminal ectodomain and a large carboxy-terminal endodomain. In this study, we showed co-purification of the M
protein from coronavirus infectious bronchitis virus (IBV) with actin. To understand the cellular factors that may be involved
in virion assembly, budding and maturation processes, IBV M was used as the bait in a yeast two-hybrid screen, resulting in
the identification of b-actin as a potentially interacting partner. This interaction was subsequently confirmed by
coimmunoprecipitation and immunofluorescence microscopy in mammalian cells, and mutation of amino acids A159 and
K160 on the M protein abolished the interaction. Introduction of the A159-K160 mutation into an infectious IBV clone
system blocks the infectivity of the clone, although viral RNA replication and subgenomic mRNA transcription were actively
detected. Disruption of actin filaments with cell-permeable agent cytochalasin D at early stages of the infection cycle led to
the detection of viral protein synthesis in infected cells but not release of virus particles to the cultured media. However, the
same treatment at late stages of the infection cycle did not affect the release of virus particles to the media, suggesting that
disruption of the actin filaments might block virion assembly and budding, but not release of the virus particles. This study
reveals an essential function of actin in the replication cycle of coronavirus.
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Introduction
Enveloped viruses acquire their envelope by budding from the
host cell. In this process, viral envelope proteins gather at a special
membranous structure and cooperate with other viral components
to induce budding [1]. For example, some viruses including
human immunodeficiency virus bud from the plasma membrane
and release the virion from host cells by pinching-off. Others are
budding at intracellular membranes [2,3]. In this way, virions are
wrapped within intracellular membrane-bound compartments,
such as the endoplasmic reticulum (ER) and Golgi apparatus, and
the newly budded viruses exit the cell by using the cellular
secretory pathway [2]. However, the detailed mechanisms of viral
assembly and budding, especially the host factors that are involved
in these processes, are yet to be revealed for many viruses. In this
study, we report that interaction between coronavirus membrane
protein (M) and actin with functional implication in facilitating
virion assembly and budding.
Coronavirus is an enveloped virus with a large, positive-
stranded RNA genome of about 27 to 31 kilobases in length. The
avian coronavirus Infectious bronchitis virus (IBV) belongs to the
third group of coronaviruses genus. Like many other coronav-
riuses, IBV virion is built from four structural proteins, including
the nucleocapsid (N) protein with which the genomic RNA is
packed, the spike (S) protein that forms the prominent coronavirus
spikes, the M protein which is the most abundant component of
coronavirus, and the envelope (E) protein which is a minor but yet
critical component in virion assembly [4]. Some group II
coronaviruses also encode an additional structural protein, the
hemagglutinin-esterase (HE).
Coronaviruses are known to assemble and bud at membranes
of the intermediate compartment (IC), locating between the ER
and Golgi complex [5]. The M protein is a type III membrane
protein and a key player in coronavirus assembly. It spans the
membrane bilayer three times, leaving a short amino-terminal
domain on the virion exterior surface (or exposed luminally in
intracellular membranes) and a large carboxy-terminal tail in the
virion interior (or in the plasma) [6]. Lateral interactions between
M proteins are thought to mediate the formation of the virion
envelope [7]. When expressed alone, M protein accumulates in
the Golgi complex in the form of homomultimeric complexes
[8,9]. However, in combination with the E protein, M is retained
in the budding compartment and incorporated into virus-like
particles (VLPs) with similarity in size and shape to authentic
virions, demonstrating that the M and E proteins are the
minimal requirements for envelope formation for most corona-
viruses, [10]. The M protein appears to interact with S and HE
proteins, and the S-M-HE protein complexes can be detected in
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was also shown to interact with the mouse hepatitis virus (MHV)
nucleocapsid consisting of the genomic-size mRNA 1 and N
protein in a pre-Golgi compartment, probably at the ER
membrane. It may interact directly with the genomic RNA
through the packaging signal, initiating the M-nucleocapsid
interaction [11]. There is also a detectably direct interaction
between M and N proteins in the nucleocapsid, which may
further stabilize the M-genomic RNA interaction [11].
Actin is the most abundant protein in a typical eukaryotic cell,
accounting for about 15% in some cell types [12]. The protein is
highly conserved, differing by no more than 5% between species as
diverse as algae and humans. It polymerizes in a helical fashion to
form actin filaments (or microfilaments) that form the cytoskeleton,
a three-dimensional network inside a eukaryotic cell. Actin
filaments provide mechanical support for the cell, determine the
cell shape, enable cell movements (through lamellipodia, filopodia,
or pseudopodia), and participate in certain cell junctions, in
cytoplasmic streaming and in cell contraction during cytokinesis
[13].
In the present study, actin was shown to be co-purified with the
IBV particles and was identified as a potential interacting protein
of the IBV M protein. The interaction was subsequently confirmed
by coimmunoprecipitation and immunofluorescent staining.
Mutation of amino acids A159 and K160 in the M protein
abolished the interaction. Introduction of the A159-K160
mutation into an infectious IBV clone system showed no infectious
virus could be recovered, although viral RNA replication and
subgenomic mRNA transcription were detected. Furthermore,
treatment of the infected cells with cell-permeable agent
cytochalasin D at early, but not late, stages of the replication
cycle showed no release of the virion to the cultured media,
suggesting that disruption of actin filaments might block virion
assembly and budding.
Materials and Methods
Yeast two-hybrid screening
Yeast two-hybrid screening was performed with the pretrans-
formed MATCHMAKER human bone marrow cDNA library
(Clontech) according to the instructions of the manufacturer. In
brief, the bait plasmid was transformed into yeast strain AH109,
and transformants containing the bait plasmid were mated with
the pretransformed cDNA library. Candidates were initially
selected on SD-Ade/-His/-Leu/-Trp plates, and plasmid DNA
was isolated from positive clones and sequenced according to the
instructions of the manufacturer.
Cell culture and transfection
H1299 and Vero cells were cultured in RPMI-1640 and
complete Dulbecco’s modified Eagle’s medium (Invitrogen),
respectively, supplemented with 10% new born calf serum (Sterile)
and 1% penicillin/streptomycin (Invitrogen) and maintained at
37uC in humidified 5% CO2.
Constructs containing plasmid DNA under the control of a T7
promoter were transiently expressed in mammalian cells using a
vaccinia virus-T7 system. Briefly, 90% monolayers of H1299 cells
were infected with 10 plaque forming units (PFU)/cell of the
recombinant vaccinia virus (vTF-3), which express the T7 RNA
polymerase gene, for 2 hours at 37uC prior to transfection. The
plasmid DNA was transfected into vTF-3 infected cells using
Lipofectamine 2000 reagent according to the instructions of the
manufacturer (Invitrogen).
Coimmunoprecipitaion
HeLa cells transfected with appropriate plasmids were lysed
with TNTG lysis buffer (30 mM Tris-HCl pH 7.4, 150 mM
NaCl, 1% NP40, and 10% glycerol) in the presence of 16protease
inhibitor mixture (Sigma) at 24 hours post-transfection. Total cell
lysates were immunoprecipitated with appropriate antibodies for
2 hours at 4uC and further incubated for 2 hours at 4uC after
adding buffer-balanced protein A agarose beads. The beads were
washed three times and subjected to electrophoresis on SDS-12%
polyacrylamide gel.
Indirect immunofluorescence
IBV M protein was transiently expressed in H1299 cells grown
on 4-well chamber slides (IWAKI). After rinsing with phosphate-
buffered saline (PBS), cells were fixed with 4% paraformaldehyde
for 15 minutes at room temperature and permeabilized with 0.2%
Triton X-100, followed by incubating with specific antibodies
diluted in fluorescence dilution buffer (PBS with 5% newborn calf
serum) at room temperature for 2 hours. Cells were then washed
with PBS, incubated with FITC-conjugated anti-rabbit secondary
antibodies (DAKO) in fluorescence dilution buffer at 4uC for
1 hour and with Alexa Fluor 488 Phalloidin (Molecular Probe) at
RT for 20 minutes before mounting. Confocal microscopy was
performed on a Zeiss microscope.
Western blot analysis
Samples were lysed with 26SDS loading buffer and subjected to
10% SDS-PAGE. Proteins were transferred to PVDF membrane
(Bio-Rad) by using a semi-dry transfer cell (Bio-Rad, Trans-blot
SD), and blocked overnight at 4uC with 10% nonfat milk in PBS-
T. The membranes were probed with specific primary antibodies
followed by anti-mouse or anti-rabbit secondary antibodies
conjugated with harderadish peroxidase (Sigma). Membrane-
bound antibodies were detected with the enhanced chemilumi-
nescence (ECL) detection reagents (Amersham, UK).
Sucrose gradient purification of coronavirus
The virus was layered onto 20% TNE-buffered sucrose solution
(TNE buffer: 50 mM Tris-Hcl, pH 7.4, 100 mM Nacl, 1 mM
EDTA) and centrifuged at 175,0006g for 3 hours at 4uC
(cushion). The resulting virus pellets were resuspended in TNE
buffer, layered onto 10–50% linear sucrose gradient prepared with
TNE buffer, and centrifuged at 175,0006g for 18 hours at 4uC.
Aliquots of fractions starting from the top of the gradient were
analyzed by SDS-PAGE.
In vitro assembly and transcription of full-length cDNA
clones
In vitro assembly and transcription of full-length cDNA clones
were carried as previously described [14]. Briefly, plasmids were
digested with either BsmBI (fragment A) or BsaI (fragments B, C,
D and E). Bands corresponding to each of the fragments were cut
from the gels and purified with QIAquick gel extraction kit
(QIAGEN Inc.). All the fragments were ligated with T4 DNA
ligase at 16uC overnight. The final ligation products were
extracted with phenol/chloroform/isoamyl alcohol (25:24:1),
precipitated with ethanol, and detected by electrophoresis on
0.8% agarose gels.
Full-length transcripts and N transcripts (using a linearized
pKT0-IBVN containing IBV N gene and the 39-UTR region as
templates) were generated in vitro using the mMessage mMachine
T7 kit (Ambion, Austin, Tex) according to the manufacturer’s
instructions.
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Vero cells
Vero cells were grown to 90% confluence, trypsinized, washed
twice with cold PBS, and resuspended in PBS (14). RNA
transcripts were added to 400 ml of Vero cell suspension in an
electroporation cuvette, and electroporated with one pulse at
450 V, 50 mF with a Bio-Rad Gene Pulser II electroporator. The
transfected Vero cells were cultured overnight in 1% FBS-
containing DMEM in a 60 mm dish and further cultured in
DMEM without FBS.
Reverse transcription, RT-PCR, and real-time PCR
Viral RNA was reverse-transcribed to cDNA using SuperScript
III (Invitrogen) with modification to the protocol as follows:
Random hexamers (300 ng) and total RNA (5 mg) were incubated
for 10 minutes at 70uC. The remaining reagents were added
according to the manufacturer’s recommendation and the reaction
was incubated at 55uC for 1 hour followed by 20 minutes at 70uC
to inactivate the RT. For RT-PCR, a forward primer in the leader
sequence and a reverse primer were used to generate a product by
PCR. Quantitative real time RT-PCR was conducted using Smart
Cycler II (Cepheid) with SYBR green (Cepheid) to detect
subgenomic cDNA with primers (7.5 pM) optimized to detect a
product spanning the leader sequence to the 59 end of M gene or
genomic cDNA with primers (7.5 pM). The cDNA from the RT
reaction of each virus was diluted 1:10, and 1 ml was used for each
PCR, with a total reaction volume of 25 ml.
Plasmid construction
M gene was cloned by digesting pIBVM with NcoI and EcoRI,
and inserted into EcoRI/NcoI digested pGBKT7 to generate
pGBKT7-M. The PCR fragment for actin was amplified by using
primers 59-CGCGGATCCATGGATGATGATATCGCCGCG-39
and 59-CCGCTCGAGGAAGCATTTGCGGYGGACGAT-39.
The PCR fragment was digested with BamHI and XhoI and ligated
into BamHI and XhoI digested pXJ-myc to generate pXJ-myc-actin.
The deletion constructs MD1, MD2, MD3, MD4 and MD5
were made by two rounds of PCR as described previously [15].
The primer used for MD1i s5 9-AACTGCAGTTAAGC-
AAGCCACTGACCCTC-39. The primers used for MD2 are
59-TCTTTTGTAGGTTATAAGTGTGAACCAGAC-39 and
59-GTCTGGTTCACACTTA TAACCTACAAAAGA-39. The
primer for MD3i s5 9-AACTGCAGCCGCTTT GGTCACCAG-
39. The primers for MD4 are 59-TGTGAGGGTCCAGAC-
CACTTG-39 and 59-CAAGTGGTCTGGACCCTCACA-3. The
primers for MD5 are 59-GGTCAGTGGC TTTGTGAA-
CCAGAC-39 and 59-GTCTGGTTCACAAAGCCACTGACC-
3. All constructs were confirmed by automated nucleotide
sequencing.
Results
Co-purification of actin with IBV
In a previous study, it was observed that a cellular protein with
migration properties on SDS-PAGE similar to actin was
consistently co-purified with highly purified IBV particles [16].
However, as no suitable antibodies against actin were readily
available at the time, the identity of this protein was not
established. This issue was revisited in this study. Confluent
monolayers of Vero cells were infected with IBV at a multiplicity
of infection of approximately 2 PFU/cell. The supernatants were
collected at 18 hours post-infection and centrifuged at 4,000 rpm
for 20 minutes to remove cell debris. The virus particles were spun
down by ultracentrifugation through a 2 ml sucrose cushion
(20%), and purified using a 10–50% sucrose gradient. Following
ultracentrifugation, 11 fractions were collected from top to
bottom, and the presence of viral proteins was checked by
Western blot with anti-N antibodies, showing that the IBV N
protein was detected in fractions 7–11 with majority of the protein
located in fractions 8–10 (Fig. 1, top panel). Analysis of the same
fractions by Western blot with anti-actin antibodies showed that
actin appeared in the same fractions as N protein, with the
majority of the protein detected in fractions 8–10 (Fig. 1, middle
panel). Fractionation of total lysates from cells without IBV
infection under the same conditions showed that actin was mainly
detected in fractions 3–4 (Fig. 1, bottom panel). These results
demonstrate that actin could indeed be co-purified with the virus
particles. However, it is currently uncertain if actin could be
incorporated into the virions.
Interaction of the IBV M protein with b-actin
In an attempt to search for IBV proteins that may interact with
b-actin, IBV structural and nonstructural proteins were used as
baits to screen a human cDNA library in yeast two-hybrid
screening. Among all the IBV proteins used, only the C-terminal
cytoplamsic portion of the IBV M protein was able to interact with
b-actin.
To confirm the interaction by co-immunoprecipitation, the full-
length cDNA for b-actin was amplified by RT-PCR from HeLa
cells, cloned into an expression vector with a c-Myc tag at its N-
terminus (Myc-actin), and co-transfected into HeLa cells with the
IBV M. Analysis of cells expressing the Myc-tagged actin either on
its own or together with the M protein by Western blot with anti-
Myc monoclonal antibody showed the detection of the Myc-
tagged actin (Fig. 2, lanes 1 and 3). Similarly, analysis of cells
expressing the M protein either on its own or together with the
Figure 1. Co-Purification of actin with IBV virions. Confluent
monolayers of Vero cells were infected with IBV at a multiplicity of
infection of approximately 2 PFU/cell. At 18 hours post-infection, the
supernatants were collected, centrifuged at 4,000 rpm for 20 minutes
to remove cell debris. The virus was pelleted by ultracentrifugation
through a 2 ml surcrose cushion (20%) at 175,0006g for 3 hours and
further purified using a linear gradient of 10–50% sucrose at 175,0006g
for 18 hours. Eleven fractions from top to bottom were collected and
separated by SDS-PAGE. Polypeptides were analyzed by Western blot
with anti-N antibodies (upper panel) and anti-actin antibodies (lower
panel). Total lysates prepared from confluent monolayers of Vero cells
were ultra-centrifuged at 175,0006g for 18 hours on a linear gradient of
10–50% sucrose. Eleven fractions from top to bottom were collected
and separated by SDS-PAGE. Polypeptides were analyzed by Western
blot with anti-actin antibodies.
doi:10.1371/journal.pone.0004908.g001
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antibodies showed the detection of the full-length glycosylated
(two upper bands) and unglycosylated (25 kDa) forms of the M
protein (Fig. 2, lanes 5 and 6). The same cell lysates were then
subjected to immunoprecipitation with anti-Myc antibody.
Western blot analysis of the precipitates with the same anti-Myc
antibody showed the detection of the Myc-tagged actin expressed
either on its own or together with the M protein (Fig. 2, lanes 7
and 9). Western blot analysis of the same precipitates with anti-M
antibodies showed the detection of the M protein only in cells co-
expressing the two proteins (Fig. 2, lane 12). No detection of the M
protein was found in cells expressing either the M protein or Myc-
actin alone (Fig. 2, lanes 10 and 11). These results confirm that the
IBV M protein could indeed interact with actin.
Mapping of the interacting region in the M protein
To map the region in the M protein responsible for the
interaction with actin by yeast two-hybrid screening, five deletion
and one mutation constructs were made (Fig. 3a). In Figure 3a,
MD1 contains the amino acid sequence from 104 to 159 (with
deletion of amino acids 160 to 225); MD2 contains the deletion of
amino acids 104–159; MD3 contains the amino acid sequence
from 104 to 192 (with deletion of amino acids 193 to 225); MD4
contains the deletion of amino acids 155–162; and MD5 contains
the deletion of amino acids 159–160 (Fig. 3a). The mutant
construct Mm1 contains the mutation of amino acids 159 and 160
from alanine and lysine to proline and glutamic acid, respectively
(Fig. 3a). Introduction of individual deletion and mutant constructs
into the yeast stain AH109 together with pACT-actin showed
growth of wild type and MD3 constructs on SD-Trp/-Leu/-His/
-Ade selective plates (Fig. 3b). However, none of the other deletion
and mutant constructs could grow on the same plate (Fig. 3b).
Western blot analysis showed similar expression levels of wild type
and mutant constructs in yeast (data not shown). As MD5 contains
the minimal deletion of two amino acids, this study maps the actin-
binding site on the M protein to the region containing amino acids
A159 and K160.
Co-immunoprecipitation was then carried out by expressing the
Myc-tag wild type M (C-terminal domain from amino acid 104 to
225, Myc-M) and Myc-Mm1 in cells. Western blot analysis with
anti-Myc monoclonal antibody showed the expression of Myc-M
and Myc-Mm1 at a similar level (Fig. 3c, upper panel, lanes 1 and
2). The same cell lysates were then subjected to immunoprecip-
itation with anti-actin antibody, and Western blot analysis of the
precipitates with anti-Myc antibody showed the presence of Myc-
M but not Myc-Mm1 (Fig. 3c, lower panel, lanes 1 and 2). The
detection of Myc-M in the immunoprecipitates was greatly
enhanced by co-expression of Myc-M and actin (Fig. 3b, lane 4).
Colocalization of the M protein with actin in cells treated
with cytochalasin D
As a type III membrane protein with three transmembrane
domains, the IBV M protein is mainly localized to the Golgi
apparatus in virus-infected cells and in cells expressing the M
protein [8]. Cytochalasin D is a cell-permeable fungal toxin. It can
bind to the barbed end of actin filaments and inhibit both the
association and dissociation of actin subunits, resulting in the
disruption of actin filaments and inhibition of actin polymeriza-
tion. To test the subcellular localization of the M protein in cells
treated with cytochalasin D, H1299 cells were transfected with M
construct and 12.5 mg/ml of cytochalasin D was added to the cells
at 4 hours post-transfection. Cells were permeabilized with 0.2%
Triton X-100 and stained with anti-M antibodies at 48 hours post-
transfection. The same cells were also stained with Alexa Fluor
488 Phalloidin, a specific dye for actin (Molecular Probe). Staining
of cells treated with DMSO and Alexa Fluor 488 Phalloidin
showed a normal three-dimensional network (Fig. 4, upper panels).
Staining of cells treated with cytochalasin D and Alexa Fluor 488
Phalloidin showed that the regular cell actin filaments were
destroyed (Fig. 4, lower panels), displaying random distribution of
actin dots in cells without the M protein expression. In cells
expressing the M protein, both M protein and actin were found
mainly in the Golgi area with fairly well overlapping of the two
staining patterns (Fig. 4, lower panels).
Effects of deletion and mutation of amino acid residues
A159 and K160 on the replication, budding and release
of IBV
Two approaches were used to test the effect of deletion and
mutation of amino acid residues A159 and K160 in the M protein
on the replication, budding and release of IBV. First, the A159-
K160 deletion and mutation were introduced into a full-length
IBV infectious clone, and the effect of this minimal deletion and
mutation on the replication of viral RNA and the recovery of
infectious IBV was analyzed. Introduction of full-length transcripts
derived from wild type (wt), the A159-K160 deletion construct
(MD5) and A159-P/K160-E mutation construct (Mm1) into Vero
cells by electroporation showed efficient recovery of infectious IBV
from cells transfected with wild type transcripts. However, it was
consistently observed that no infectious virus could be recovered
from cells transfected with either MD5 or Mm1 transcripts.
As no infectious virus was recovered from cells transfected with
MD5 and Mm1 transcripts, RT-PCR amplification of the negative
strand RNA was performed to check if RNA replication occurred
in the transfected cells. The primer pair (59-
14931GCTTATC-
CACT AGTACATC
14949-39 and 59-
15578CTTCTCGCACTTC-
TGCACTAGCA
15600-39) was chosen to amplify the negative
strand IBV sequence from nucleotides 14931 to 15600 by the RT-
PCR. If replication of viral RNA occurred, a 670 bp PCR
fragment would be expected. As shown in Fig. 5a, the 670 bp RT-
PCR fragments were obtained from cells transfected with both
wild type and mutant transcripts at 24 and 72 hours post-
transfection, respectively (upper panel, lanes 2–7). Interestingly,
the amounts of the fragment detected from cells transfected with
Figure 2. Interaction of the IBV M protein with human b-actin.
HeLa cells were transfected with the Myc-tagged actin alone (lanes 1, 4,
7 and 10), IBV M alone (lanes 2, 5, 8 and 11) or cotransfected with actin
and IBV M (lanes 3, 6, 9 and 12). Cells were harvested at 24 hours post-
transfection and lysates prepared. Polypeptides were either analyzed
directly by Western blot with anti-Myc (lanes 1–3) and anti-IBV M (lanes
4–6) antibodies, or subjected to immunoprecipitation with anti-Myc
antibodies. The precipitates were analyzed by Western blot with anti-
Myc (lanes 7–9) and anti-IBV M (lanes 10–12) antibodies. Numbers on
the left indicate molecular masses in kilodaltons.
doi:10.1371/journal.pone.0004908.g002
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transfection (Fig. 5a, upper panel, lanes 3–4 and 6–7), demon-
strating the replication of the transfected mutant transcripts. No
RT-PCR fragment was detected in cells without transfection
(Fig. 5a, upper panel, lane 1).
RT-PCR amplification of subgenomic mRNAs was then carried
out to check if subgenomic mRNA synthesis could occur in cells
transfected with the mutant transcripts at 24 and 72 hours post-
electroporation. The forward primer (59-ACTTAAGATAGA-
TATTA A-39) used in this reaction corresponds to the leader
sequence from nucleotides 26–46 in the genomic RNA and the
downstream primer (59-CTCTGGATCCAATAACCTAC-39)
covers the IBV sequence from nucleotides 24784 to 24803. If
transcription of subgenomic mRNAs occurs, a 415 bp PCR
product corresponding to the 59-terminal region of the sub-
genomic mRNA4 would be detected. As shown in Fig. 5a, a
dominant 415 bp was observed in cells electroporated with wild
type full-length transcripts at two time points (lower panel, lanes 2
and 5). In cells transfected with MD5 and Mm1 transcripts, a
much weaker band was detected in cells transfected with the two
mutant transcripts at 24 hours post-transfection (Fig. 5a, lower
panel, lanes 3–4). Similarly to the results described above, the
amounts of the subgenomic RNA 4 fragment detected from cells
transfected with MD5 and Mm1 transcripts were increased
approximately 3 to 5 fold, respectively, at 72 hours post-
transfection based on real time PCR assay (Fig. 5a, lower panel,
lanes 3–4 and 6–7). As a negative control, no detection of the
amplified fragments was obtained from a mixture of RNA
templates containing the in vitro transcribed RNA and total RNA
extracted from mock infected cells (Fig. 5a, lower panel, lane 1).
In the second approach, plasmids containing wild type M
(pIBVM) and the A159-K160 deletion M sequences (pMD5) were
transfected into H1299 cells using the vaccinia/T7 recombinant
virus expression system. H1299 cells are a continuous cell line
derived from human lung carcinoma. This cell line can be
efficiently infected by the Vero cell-adapted IBV [17] and is much
more resistant to the vaccinia virus-induced morphological
changes. At 16 hours post-transfection, the cells were infected
with IBV at a multiplicity of infection of approximately 0.5 PFU/
cell, and were harvested at 24 hours post-infection. The expression
of M protein and the infectivity of IBV on these cells were
analyzed by Western blot with anti-M and anti-N polyclonal
Figure 3. Mapping the region on M protein responsible for interaction with b-actin. a. Diagram showing the wild type IBV M and six
deletion and mutation constructs (MD1, MD2, MD3, MD4, MD5 and Mm1). The two N-linked glycosylation sites (N-gly), three transmembrane
domains (Tm1-3) and the C-terminal cytoplasmic domain of the M protein are highlighted. Also shown are the amino acid positions of the deleted
and mutated region in each construct. b. The wild type IBV M and the six deletion and mutation constructs, respectively, were transformed into yeast
cells with pACT-actin. The growth of the yeast cells on SD-Trp/-Leu/-His/-Ade- plate is shown. Also shown are the positive and negative controls. c.
Co- immunoprecipitation of wild type M (the C-terminal region from amino acids 104–225) but not Mm1 with with human b-actin. HeLa cells were
transfected with the Myc-tagged wild type M (Myc-M) (lane1), Myc-Mm1 (lane 2), empty vector (lane 3) or Myc-M+actin (lane 4). Cells were harvested
at 24 hours post-transfection and lysates prepared. Polypeptides were either analyzed directly by Western blot with anti-Myc (upper panel), or
subjected to immunoprecipitation with anti-actin antibodies. The precipitates were analyzed by Western blot with anti-Myc antibody (lower panel).
LC-light chain.
doi:10.1371/journal.pone.0004908.g003
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type and MD5 constructs with or without IBV infection, detection
of similar amounts of M protein was observed (Fig. 5b, top two
panels, lanes 1 and 2), suggesting that both constructs were
expressed at similar efficiencies. However, much more N protein
was detected in the infected cells transfected with wild type M
construct than that in cells transfected with the MD5 mutant
(Fig. 5b, middle panel, lanes 1 and 2). As a loading control, similar
amounts of actin were detected in cells transfected with both
constructs (Fig. 5b, bottom panel). These results confirm that
expression of the A159-K160 deletion M protein significantly
reduces the infectivity of IBV, suggesting that expression of this
mutant protein could inhibit the production of infectious virus in a
dominant-negative manner.
To rule out the possibility that the deletion and mutation may
render detrimental effect on the overall structure of the M protein
and its interaction with other viral proteins that are essential for
virion assembly, interaction of the Mm1 mutant with the E protein
was tested by co-immunoprecipitation. As shown in Fig. 5c,
Western blot analysis with anti-IBV E protein antibodies showed
the presence of E protein in cells expressing the protein on its own
or together with wild type or Mm1 mutant protein (top panel).
Immunoprecipitation of the same lysates with anti-M antibodies
and subsequent analysis of the precipitates by Western blot with
anti-M antibodies led to the detection of wild type or the Mm1
mutant proteins in cells expressing M forms either alone or
together with the E protein (Fig. 5c, middle panel). Western blot
analysis of the same precipitates with anti-IBV E antibodies,
however, showed the presence of E protein only if it was co-
expressed with either wild type or the Mm1 mutant protein
(Fig. 5c, bottom panel). These results confirm that the A159-P/
K160-E mutations did not affect the interaction between IBV M
and E proteins.
Effects of disruption of actin filaments by cytochalasin D
on the replication, budding and release of IBV
To define more precisely the stage of the viral replication cycle
that is facilitated by the interaction between M protein and actin,
the effects of disrupting actin filaments by cytochalasin D on the
replication, budding and release of IBV were tested by detailed
time-course experiments. Confluent monolayers of Vero cells in
six-well plates were infected with IBV at a multiplicity of infection
of approximately 3 PFU/cell. At 0, 4, 8, 12 and 16 hours post-
infection, either 12.5 mg/ml of cytochalasin D or equal volume of
DMSO was added to the cells. The supernatants and cell pellets
were separately harvested at 24 hours post-infection and the
presence of IBV N protein was checked by Western blot with anti-
N antibodies. Typical N protein profiles, including the full-length
and posttranslationally modified forms of the protein, were
detected in the total cell lysates (Fig. 6, top panel). In cells treated
with cytochalasin D, slightly less amounts of the N protein were
detected when cytochalasin D was added to the cells at 0, 4, 8 and
12 hours post-infection, respectively (Fig. 6, top panel, lanes 1–4).
No obvious difference in the expression of N protein was seen
when cytochalasin D was added at 16 hours post-infection (Fig. 6,
top panel, lane 5). Western blot analysis of actin was included as a
loading control (Fig 6, middle panel). Analysis of the N protein in
the clarified supernatants showed the detection of a single N
protein species that represents the N protein incorporated into the
virion particles in cells treated with DMSO alone (Fig. 6, bottom
panel, lanes 6–10). In supernatants collected from cells treated
with cytochalasin D, much reduced amounts of the N protein were
detected in cells treated with the reagent at 12 and 16 hours post-
infection, respectively (Fig. 6, bottom panel, lanes 4 and 5). No N
protein was detected in supernatants harvested from cells treated
with cytochalasin D at 0, 4 and 8 hour post-infection, respectively
(Fig. 6, bottom panel, lanes 1–3).
Figure 4. Colocalizaion of M and actin proteins in cells. The plasmids containing M gene were transfected into H1299 cells. At 4 hours post-
transfection, the cells were treated by cytochalasin D (12.5 mg/ml) and permeabilized with 0.2% Triton X-100 and stained with anti-M antibodies at
48 hours post-transfection. The same cells were also stained with actin dye Alexa Fluor 488 Phalloidin (green).
doi:10.1371/journal.pone.0004908.g004
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Coronavirus M protein plays essential roles in virion assembly
and budding [18,19]. The protein itself cannot bud. However,
with the help of E protein, VLPs may be formed at the IC
membranes. As coronaviruses do not contain a matrix protein that
underlines the membrane, the M protein may serve as a matrix-
like protein. It is proposed that the formation of coronavirus
envelope is dominated by lateral interaction between M molecules
that form a two-dimensional lattice in intracellular membranes
[20]. The M-M interaction is essential but not sufficient for
coronavirus envelope assembly. Free energy is needed to generate
and stabilize membrane curvature, suggesting that interaction of
M protein with host proteins would be a must [21]. To support
this speculation, the results present in this study demonstrate that
interaction of the IBV M protein with b-actin is essential for virion
assembly and budding. The interacting region in the M protein
was pinpointed by deletion and mutation studies. As MD3 is able
to interact with actin, but MD1 and MD2 could not, it was
reasoned that the domain responsible for this interaction may be
located in the region covering amino acids 159–160. This region
was chosen for further deletion and mutational analysis,
confirming that it is indeed involved in the interaction with actin.
However, the two amino acids are not conserved in other
coronavirus M proteins. At present, we do not know whether
interaction between coronavirus M protein and actin is a general
phenomenon for all coronaviruses, or is just IBV-specific.
Available evidence suggests that the host cytoskeleton, especially
actin, is involved in the budding process of several animal viruses
[22]. Actin has been identified in many enveloped viruses, such as
Rous sarcoma virus, mouse mammary tumor virus, Sendai virus
and measles virus. In the case of measles virus, actin was originally
thought as a cellular contaminant, but was later demonstrated to
be an internal component of the virus [23–25]. Actin was found in
the purified paramyxovirus particles and actin filaments were seen
in association with the budding virions by electron microscopy
[24–26]. Polymerized actin was also found in HIV preparations
[27,28]. The functional implication for the incorporation of actin
into these virus particles remains unclear. One possibility is that
actin polymerization serves as an additional force for membrane
bending during budding [1,29]. As an illustrative example, actin
was shown to control the movement of measles virus envelope
proteins on the surface of infected cells [30].
Figure 5. Effects of A159-K160 deletion and mutation on
replication and infectivity of IBV. a. In vitro transcripts derived from
wild type, MD5 and Mm1 full-length IBV clones were electroporated
into Vero cells. At 24 and 72 hours post-electroporation, total RNA were
extracted from the cells and specific primers were used to detect the
minus RNA (upper panel) and subgenomic mRNA 4 (lower panel) by RT-
PCR. b. H1299 cells expressing wild type IBV M and MD5 constructs with
a vaccinia virus system were infected with IBV at a multiplicity of
infection of approximately 0.5 PFU/cell. Cells were collected at 24 hours
post-infection and polypeptides were analyzed by Western blot with
anti-IBV M (second panel), anti-IBV N (third panel) and anti-actin
(bottom panel) antibodies. H1299 cells expressing wild type IBV M and
MD5 constructs with a vaccinia virus system without IBV infection
harvested at 40 hours post-transfection were also analyzed by Western
blot with anti-IBV M antibodies (top panel). c. Interaction of Mm1
mutant M protein with IBV E protein. H1299 cells expressing the E (lane
1), M (lane 2) and E+M (lane 3) and E+Mm1 were harvested at 24 hours
post-transfection and lysed. The total cell lysates were either detected
directly by Western blot with anti-E antibodies (top panel) or
immunoprecipitated with anti-M antibodies. The precipitates were
analyzed by Western blot with anti-M (middle panel) and anti-E (bottom
panel) antibodies, respectively.
doi:10.1371/journal.pone.0004908.g005
Figure 6. Effects of disruption of actin filaments by cytocha-
lasin D on IBV replication. Vero cells plated in six-well plates were
infected with IBV at a multiplicity of infection of approximately 3 PFU/
cell. Cytochalasin D (12.5 mg/ml) and DMSO were added to the infected
cells at indicated time. Total cells and the culture media were separately
collected at 24 hours post-infection. Cell lysates were prepared and
analyzed by Western blot with anti-N (top panel) and anti-actin (middle
panel) antibodies. Western blot analysis of the IBV N protein in the
culture media with anti-N antibodies (bottom panel) was also shown.
doi:10.1371/journal.pone.0004908.g006
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several other viral systems. One example is the interaction of the
nuclocapsids of murine mammary tumor virus with actin, which
was required for extruding the virus particles from virus-infected
cells [31]. The M protein of Newcastle disease virus could interact
with actin in vitro [1,32]. The SARS-CoV N protein could
aggregate elongation factor 1a through direct interaction, leading
to the inhibition of protein translation and cytokinesis by blocking
F-actin bundling [33]. It was also reported that the SARS-CoV N
protein could induce apoptosis and actin reorganization in
mammalian cells under stress conditions [34]. The results shown
in this study demonstrate that actin could be co-purified with IBV
virions and that the IBV M protein is associated with actin,
suggesting that actin is likely to be incorporated into IBV virions
through its interaction with the M protein. However, more
conclusive data, such as immunogold labeling of highly purified
virions, are currently lacking. It is interesting that IBV replication
cycle was disturbed in cells treated with cytochalasin D.
Cytochalsin D could prevent actin from polymerization, leading
to malfunction of actin. When actin was disrupted, much less IBV
virions were released from the cells into the culture medium,
demonstrating that actin plays a very important role in the IBV
replication cycle. Two possible mechanisms were considered. First,
actin may be involved in the formation of the M lattice that may
promote and stabilize its curving, resulting in the enhancement of
some late processes, such as virion budding and release. Second,
the MHV M protein was shown to be recycled from the Golgi
complex back to early compartments, such as the ER and IC,
which are functionally important in coronavirus infected cells [21].
Therefore, interaction of actin with M protein may help the
retrograde transport of M protein from Golgi apparatus to some
early compartments and provide more M protein for virion
assembly and budding.
The actin-binding proteins are grouped into 60 distinct classes
based on primary structures [35]. The sequence of the actin-
binding sites ranges from 10–30 residues, which shows no obvious
homology among different classes [36]. For example, Aldolase, a
glycolytic enzyme, binds actin filaments to concentrate enzyme
and substrate [37]. The sequence 32-ADESTGSIAKRLQSIG-
TENTE-52 of aldolase has been identified as the actin-binding
motif [38]. Furthermore, Carcinoembryonic Cell Adhesion
Molecule 1 (CEACAM1) was found to bind F-actin. The actin
binding site is FLHFGKTGSSGPLQ, which is not similar to other
existing actin-binding sequences [39].
Coronavirus M protein is an essential and predominant
component of the virions. It plays pivotal roles in virion assembly
and budding by interaction with other viral components. Firstly,
the monomers of M could interact with each other particularly via
the transmembrane domains [21]. Besides, the M-N interaction
region was narrowed to the 16 residues adjacent to the carboxy
terminus of TGEV M protein [40]. However, the specific amino
acids on M protein responsible for M-S and M-E interactions are
still enigmatic. In the present study, deletion or mutation of amino
acids A159 and K160, which are essential for the interaction of M
protein with actin, is detrimental to the recovery of IBV from an
infectious IBV clone due to a defect in late stages of the IBV
replication cycle. Although, the deletion or mutation of amino
acids A159 and K160 could also interact with another structural
protein E, we cannot exclude the possibility that this region is
essential for maintaining the integrity of the M protein and
involved in the interactions with other viral components.
Nevertheless, it lends support to the conclusion that interaction
of the IBV M protein with actin is essential for the completion of
the IBV infection cycle.
More evidence is derived from the study using cytochalasin D.
Similar amount of viral proteins were detected in the total cell
lysates but were not detected in supernatants when cytochalasin D
was added early in the viral replication cycle suggests that actin
filaments are essential for some early events, such as virion
assembly and budding, during the assembly and maturation
processes of IBV. As IBV proteins can be efficiently detected in the
supernatants when cytochalasin D was added at 12 and 16 hours
post-infection, respectively, it suggests that actin filaments are
unlikely involved in the release of the IBV particles. Instead, our
data support that actin filaments may be involved in the virion
assembly and budding process of the coronavirus replication
cycles. As coronavirus M protein could bind to the viral genomic
RNA through packaging signal [41] and RNA replication in the
cytoplasm would rely on the support of actin [42], the interaction
of M protein with actin may serve as a platform to promote the
binding of M protein to viral RNA as well as viral RNA
replication. Alternatively, coronavirus M protein could bind to the
N protein-RNA complex to stabilize the nucleocapsid [11] and
extra energy would be needed in this process [21]. The interaction
of M protein with actin may serve as a power station to provide
energy for completion of the viral replication cycle.
Author Contributions
Conceived and designed the experiments: JW HX JPT DXL. Performed
the experiments: JW SF HX BC. Analyzed the data: JW SF BC JPT DXL.
Wrote the paper: JW DXL.
References
1. Garoff H, Hewson R, Opstelten DJ (1998) Virus maturation by budding.
Mirobiol Mol Biol Rev 62: 1171–1190.
2. Griffiths G, Rottier P (1992) Cell biology of viruses that assemble along the
biosynthetic pathway. Semin Cell Biol 3: 367–381.
3. Gissen P, Maher ER (2007) Cargos and genes: insights into vesicular transport
from inherited human disease. J Med Genet 44: 545–555.
4. de Haan CAM, Kuo L, Masters PS, Vennema H, Rottier PJM (1998)
Coronavirus Particle Assembly: Primary Structure Requirements of the
Membrane Protein. J Virol 72: 6838–6850.
5. Krijnse-Locker J, Ericsson M, Rottier PJM, Griffiths G (1994) Characterization
of the budding compartment of mouse hepatitis virus: evidence that transport
from the RER to the Golgi complex requires only one vesicular transport step.
J Cell Biol 124: 55–70.
6. Rottier PJM (1995) The coronavirus membrane glycoprotein. In: The
Coronaviridae. Siddell SG, ed. New York, NY: Plnum Press. pp 115–139.
7. Nguyen V-P, Hogue BG (1997) Protein interactions during coronavirus
assembly. J Virol 71: 9278–9284.
8. Klumperman J, Krijnse-Locker J, Meijer A, Horzinek MC, Geuze HJ, et al.
(1994) Coronavirus M proteins accumulate in the Golgi complex beyond the site
of virion budding. J Virol 68: 6523–6534.
9. Krijnse-Locker J, Griffiths G, Horzinek G, Rottier PJM (1992) O-glycosylation
of the coronavirus M protein. Differential localization of sialyltransferases in N-
and O-linked glycosylation. J Biol Chem 267: 14094–14101.
10. Vennema H, Godeke G-J, Rossen JWA, Voorhout WF, Horzinek MC, et al.
(1996) Nucleocapsid-independent assembly of coronavirus-like particles by
coexpression of viral envelope protein genes. EMBO J 15: 2020–2028.
11. Narayanan K, Maeda A, Maeda J, Makino S (2000) Characterization of the
coronavirus M protein and nucleocapsid interaction in infected cells. J Virol 74:
8127–8134.
12. Winder SJ, Ayscough KR (2005) Actin-binding proteins. J Cell Sci 118:
651–654.
13. Pantaloni D, Clainche CL, Carlier M-F (2001) Mechanism of actin-based
motility. Science 292: 1502–1506.
14. Fang SG, Chen B, Tay FPL, Liu DX (2006) An arginine-to-proline mutation in
a domain with undefined function within the RNA helicase protein (NSP13) is
lethal to the coronavirus infectious bronchitis virus in cultured cells. Virology
358: 136–147.
15. Liu DX, Xu HY, Brown TDK (1997) Proteolytic processing of the coronavirus
infectious bronchitis virus 1a polyprotein: identification of a 10-kilodalton
polypeptide and determination of its cleavage sites. J Virol 71: 1814–1820.
Coronavirus M and Actin
PLoS ONE | www.plosone.org 8 March 2009 | Volume 4 | Issue 3 | e490816. Liu DX, Inglis SC (1991) Association of the infectious bronchitis virus 3c protein
with the virion envelope. Virology 185: 911–917.
17. Li FQ, Tam JP, Liu DX (2007) Cell cycle arrest and apoptosis induced by the
coronavirus infectious bronchitis virus in the absence of p53. Virology 365:
435–45.
18. Stern DF, Burgess L, Sefton BM (1982) Structural analysis of virion proteins of
the avian coronavirus infectious bronchitis virus. J Virol 42: 208–219.
19. Sturman LS, Holmes KV, Behnke J (1980) Isolation of coronavirus envelope
glycoproteins and interaction with the viral nucleocapsid. J Virol 33: 449–462.
20. Opstelten D-JE, Raamsman MJB, Wolfs K, Horzinek MC, Rottier PJM (1995)
Envelope glycoprotein interactions in coronavirus assembly. J Cell Biol 131:
339–349.
21. de Haan CAM, Vennema H, Rottier PJM (2000) Assembly of the coronavirus
envelope: homotypic interactions between the M proteins. J Virol 74:
4967–4978.
22. Arthur LO, Bess JW, Sowder RC, Benveniste RE, Mann DL, et al. (1992)
Cellular proteins bound to immunodeficiency viruses: implications for
pathogenesis and vaccines. Science 258: 1935–1938.
23. Fleissner E, Tress E (1973) Chromatographic and electrophoretic analysis of
viral proteins from hamster and chicken cells transformed by rous sarcoma virus.
J Virol 11: 250–262.
24. Lamb RA, Mahy BWJ, Choppin PW (1976) The synthesis of sendai virus
polypeptides in infected cells. Virology 69: 116–131.
25. Tyrrell DLJ, Norrby E (1978) Structural polypeptides of measles virus. J Gen
Virol 39: 219–229.
26. o ¨rvell C (1978) Structural polypeptides of mumps virus. J Gen Virol 41:
527–539.
27. Ott DE, Coren LV, Kane BP, Busch LK, Johnson DG, et al. (1996) Cytoskeletal
proteins inside human immunodeficiency virus type 1 virions. J Virol 70:
7734–7743.
28. Gardet A, Breton M, Fontanges P, Trugnan G, Chwetzoff S (2006) Rotavirus
spike protein VP4 binds to and remodels Actin bundles of the epithelial brush
border into Actin bodies. J Virol 80: 3947–3956.
29. Gov NS, Gopinathan A (2006) Dynamics of membranes driven by actin
polymerization. J Biophy 90: 454–469.
30. Ehrnst A, Sundquist KG (1975) Polar appearance and nonligand induced
spreading of measles virus hemagglutinin at the surface of chronically infected
cells. Cell 5: 351–359.
31. Ehrnst A, Sundquist KG (1976) The mechanisms of appearance of viral
glycoproteins at cell surface membrane. Exp Cell Biol 44: 198–225.
32. Ogino T, Iwama M, Ohsawa Y, Mizumoto K (2003) Interaction of cellular
tubulin with Sendai virus M protein regulates transcription of viral genome.
Biochem Biophy Res Commun 311: 283–293.
33. Zhou B, Liu J, Wang Q, Liu X, Li X, et al. (2008) The nucleocapsid protein of
severe acute respiratory syndrome coronavirus inhibits cell cytokinesis and
proliferation by interacting with translation elongation factor 1alpha. J Virol 82:
6962–71.
34. Surjit M, Liu B, Jameel S, Chow VT, Lal SK (2004) The SARS coronavirus
nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells
in the absence of growth factors. Biochem J 383: 13–8.
35. Pacholsky D, Vakeel P, Himmel M, Lo ¨we T, Stradal T, et al. (2004) Xin repeats
define a novel actin-binding motif. J Cell Sci 117: 5257–5268.
36. Vandekerckhove J, Vancompernolle K (1992) Structural relationships of actin-
binding proteins. Curr Opin Cell Biol 4: 36–42.
37. Grazi E, Guidoboni M (1989) Opposite effects of alpha-actinin and of fructose
1,6 -bisphosphate aldolase on the microfilament network. The role of
orthophosphate revisited. Biochem Int 19: 1345–1353.
38. O’Reilly G, Clarke F (1993) Identification of an actin binding region in aldolase.
FEBS lett 321: 69–72.
39. Schumann D, Chen C-J, Kaplan B, Shively JE (2001) Carcinoembryonic
antigen cell adhesion molecule 1 directly associates with cytoskeleton proteins
actin and tropomyosin. J Biol Chem 276: 47421–47433.
40. Escors D, Ortego J, Laude H, Enjuanes L (2001) The membrane M protein
carboxy terminus binds to transmissible gastroenteritis coronavirus core and
contributes to core stability. J Virol 75: 1312–1324.
41. Narayanan K, Chen CJ, Maeda J, Makino S (2003) Nucleocapsid-independent
specific viral RNA packaging via viral envelope protein and viral RNA signal.
J Virol 77: 2922–2927.
42. Lai MNC (1998) Cellular factors in the transcription and replication of viral
RNA genomes: a parallel to DNA-dependent RNA transcription. Virology 244:
1–12.
Coronavirus M and Actin
PLoS ONE | www.plosone.org 9 March 2009 | Volume 4 | Issue 3 | e4908